Side-by-Side Comparison · 2026

CJC-1295 vs GHRP-2

CJC-1295 vs GHRP-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

CJC-1295
Growth Hormone

CJC-1295 is a synthetic GHRH analog with a Drug Affinity Complex (DAC) that binds circulating albumin, extending half-life from 7 minutes to approximately 6-8 days. Enables once-weekly dosing with sustained GH elevation. Phase I/II clinical research status. WADA prohibited under ...

Calculate CJC-1295 dose →
GHRP-2
Growth Hormone

GHRP-2 (Pralmorelin) is a synthetic hexapeptide growth hormone releasing peptide and one of the most potent first-generation GHRPs. It stimulates pituitary GH secretion via the ghrelin receptor (GHSR-1a) with greater potency than GHRP-6, while producing less appetite stimulation....

Calculate GHRP-2 dose →
Key Parameters
Parameter CJC-1295 GHRP-2
Category Growth Hormone Growth Hormone
Research Extensively Studied Extensively Studied
Half-Life ~6–8 days (with DAC) ~30–60 min
Typical Dose 1–2 mg 100–300 µg
Frequency Once weekly or twice weekly 1–3× daily
Route Subcutaneous Subcutaneous
FDA Status Not Approved Not Approved (US)

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between CJC-1295 and GHRP-2?
CJC-1295: CJC-1295 is a synthetic GHRH analog with a Drug Affinity Complex (DAC) that binds circulating albumin, extending half-life from 7 minutes to approximately 6-8 days. Enables once-weekly dosing with sus... GHRP-2: GHRP-2 (Pralmorelin) is a synthetic hexapeptide growth hormone releasing peptide and one of the most potent first-generation GHRPs. It stimulates pituitary GH secretion via the ghrelin receptor (GHSR-...
Which has a longer half-life, CJC-1295 or GHRP-2?
CJC-1295 half-life: ~6–8 days (with DAC). GHRP-2 half-life: ~30–60 min.
Can you stack CJC-1295 and GHRP-2?
CJC-1295 and GHRP-2 are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.